Nutex Health (NASDAQ:NUTX) Shares Up 12.8% – Here’s Why

Nutex Health Inc. (NASDAQ:NUTX)’s stock price traded up 12.8% on Monday . The stock traded as high as $163.36 and last traded at $167.13. 71,134 shares changed hands during trading, a decline of 47% from the average session volume of 135,105 shares. The stock had previously closed at $148.19.

Wall Street Analyst Weigh In

Several brokerages have issued reports on NUTX. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Nutex Health in a report on Monday, December 29th. Wall Street Zen upgraded Nutex Health from a “buy” rating to a “strong-buy” rating in a research report on Friday, November 28th. Two equities research analysts have rated the stock with a Buy rating and one has issued a Hold rating to the company’s stock. Based on data from MarketBeat.com, Nutex Health has a consensus rating of “Moderate Buy” and an average target price of $252.50.

Nutex Health Trading Up 13.1%

The business’s fifty day moving average price is $143.47 and its 200 day moving average price is $116.33. The company has a quick ratio of 3.18, a current ratio of 3.20 and a debt-to-equity ratio of 0.67. The firm has a market capitalization of $1.19 billion, a PE ratio of 9.07 and a beta of -0.08.

Nutex Health (NASDAQ:NUTX) last announced its quarterly earnings data on Tuesday, November 18th. The company reported $7.76 earnings per share (EPS) for the quarter, beating the consensus estimate of ($5.43) by $13.19. The business had revenue of $243.99 million for the quarter, compared to the consensus estimate of $221.93 million. Nutex Health had a net margin of 11.62% and a return on equity of 37.44%.

Insider Activity

In other Nutex Health news, CFO Jon Christian Bates acquired 750 shares of the stock in a transaction dated Tuesday, November 25th. The stock was acquired at an average price of $136.71 per share, with a total value of $102,532.50. Following the completion of the transaction, the chief financial officer directly owned 5,638 shares in the company, valued at approximately $770,770.98. This trade represents a 15.34% increase in their ownership of the stock. The purchase was disclosed in a document filed with the SEC, which is available at the SEC website. 36.92% of the stock is owned by company insiders.

Institutional Trading of Nutex Health

A number of hedge funds have recently added to or reduced their stakes in the business. Pertento Partners LLP purchased a new stake in shares of Nutex Health during the 3rd quarter valued at $27,940,000. Topline Capital Management LLC raised its position in shares of Nutex Health by 80.0% in the 3rd quarter. Topline Capital Management LLC now owns 556,567 shares of the company’s stock worth $57,505,000 after buying an additional 247,436 shares during the period. Marshall Wace LLP boosted its holdings in Nutex Health by 333.4% in the second quarter. Marshall Wace LLP now owns 94,548 shares of the company’s stock valued at $11,770,000 after acquiring an additional 72,734 shares during the last quarter. Millennium Management LLC grew its position in Nutex Health by 191.1% during the third quarter. Millennium Management LLC now owns 93,396 shares of the company’s stock valued at $9,650,000 after acquiring an additional 61,308 shares during the period. Finally, Divisadero Street Capital Management LP purchased a new stake in Nutex Health during the second quarter valued at about $7,481,000. 5.32% of the stock is owned by institutional investors and hedge funds.

Nutex Health Company Profile

Nutex Health, Inc (NASDAQ: NUTX) is an integrated outpatient healthcare services company based in San Antonio, Texas. The company focuses on delivering a range of ambulatory care solutions, including urgent care, telemedicine, medical imaging, teleradiology, weight‐loss services and behavioral health support. By combining in‐person clinics with virtual care capabilities, Nutex Health aims to provide patients with accessible, cost‐effective treatment options outside traditional hospital settings.

The company’s urgent care network operates through both standalone and retail‐anchored centers, offering treatment for non‐life‐threatening injuries and illnesses, preventive screenings and basic primary care.